| In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Program management total | 674.4 | 622.9 | 597.0 | 511.4 | 422.0 | 362.1 | 316.7 | |
| Skilled nursing rehabilitation services | 496.3 | 457.2 | 432.9 | | | | | |
| Hospitals | 195.0 | 112.5 | 96.0 | 73.9 | 21.7 | | | |
| Hospital rehabilitation services | 178.2 | 165.7 | 164.1 | 179.8 | 189.8 | 190.7 | 185.8 | |
| Other | | | | | | | 36.8 | |
| Total revenues | 869.4 | 735.4 | 693.0 | 611.6 | 454.3 | 383.8 | 539.3 | 562.6 |
| Revenue growth [+] | 18.2% | 6.1% | 13.3% | 34.6% | 18.3% | -28.8% | -4.1% | |
| Program management total | 8.3% | 4.3% | 16.7% | 21.2% | 16.6% | 14.3% | | |
| Skilled nursing rehabilitation services | 8.5% | 5.6% | | | | | | |
| Hospitals | 73.3% | 17.2% | 30.0% | 240.3% | | | | |
| Hospital rehabilitation services | 7.6% | 0.9% | -8.7% | -5.3% | -0.5% | 2.6% | | |
| Healthcare staffing | | | | | | -92.5% | | |
| Cost of goods sold | 704.4 | 597.9 | 561.2 | 493.4 | 343.2 | 275.2 | 408.6 | 413.1 |
| Gross profit | 165.0 | 137.5 | 131.8 | 118.1 | 111.0 | 108.6 | 130.8 | 149.5 |
| Gross margin | 19.0% | 18.7% | 19.0% | 19.3% | 24.4% | 28.3% | 24.2% | 26.6% |
| Selling, general and administrative | 104.1 | 90.1 | 82.8 | 14.3 | 10.7 | 8.6 | 8.6 | 8.3 |
| Equity in earnings | 0.4 | 0.5 | 0.3 | -3.0 | -36.6 | -0.7 | | 39.3 |
| Other operating expenses | 16.5 | 14.6 | 16.5 | 79.4 | 62.9 | 57.1 | 91.7 | 101.5 |
| EBITDA [+] | 61.4 | 48.3 | 49.7 | 35.9 | 11.5 | 50.8 | 39.0 | 87.4 |
| EBITDA growth | 27.3% | -3.0% | 38.7% | 210.7% | -77.3% | 30.1% | -55.3% | |
| EBITDA margin | 7.1% | 6.6% | 7.2% | 5.9% | 2.5% | 13.2% | 7.2% | 15.5% |
| Depreciation and amortization | 16.5 | 14.9 | 17.0 | 14.5 | 10.7 | 8.6 | 8.6 | 8.3 |
| EBIT [+] | 44.9 | 33.4 | 32.7 | 21.3 | 0.9 | 42.2 | 30.5 | 79.0 |
| EBIT growth | 34.5% | 2.0% | 53.4% | 2296.9% | -97.9% | 38.5% | -61.5% | |
| EBIT margin | 5.2% | 4.5% | 4.7% | 3.5% | 0.2% | 11.0% | 5.6% | 14.1% |
| Non-recurring items [+] | | | 4.9 | 2.2 | 4.2 | 1.1 | 44.9 | |
| Asset impairment | | | 4.9 | 2.4 | 4.2 | | | |
| Interest expense, net [+] | 5.4 | 3.8 | 7.5 | 5.0 | 0.4 | 0.8 | 0.6 | 0.4 |
| Interest expense | 5.5 | 3.9 | 8.4 | 5.5 | 1.2 | 1.2 | 0.7 | 0.7 |
| Interest income | 0.1 | 0.1 | 0.8 | 0.5 | 0.8 | 0.4 | 0.1 | 0.3 |
| Other income (expense), net | 0.0 | 0.0 | 0.0 | 0.0 | -26.6 | -34.2 | 1.3 | -39.3 |
| Pre-tax income | 39.5 | 29.6 | 20.3 | 14.1 | -30.3 | 6.1 | -13.7 | 39.3 |
| Income taxes | 17.6 | 12.1 | 7.7 | 6.1 | -13.3 | -17.0 | 0.0 | 15.0 |
| Tax rate | 44.7% | 40.7% | 37.7% | 43.4% | 44.0% | | 0.0% | 38.0% |
| Minority interest | 2.0 | 2.0 | 0.4 | 0.0 | | | | |
| Earnings from continuing ops | 21.0 | 16.7 | 12.3 | 8.0 | -17.0 | 23.2 | -13.7 | 24.4 |
| Earnings from discontinued ops | -0.8 | -0.9 | -0.4 | | | | | |
| Net income | 21.0 | 16.7 | 12.3 | 7.3 | -17.0 | 23.2 | -13.7 | 24.4 |
| Net margin | 2.4% | 2.3% | 1.8% | 1.2% | -3.7% | 6.0% | -2.5% | 4.3% |
| |
| Basic EPS [+] | $1.22 | $1.05 | $0.73 | $0.47 | ($1.01) | $1.42 | ($1,609.00) | $1.45 |
| Growth | 16.2% | 43.8% | 54.8% | -146.7% | -171.1% | -100.1% | -111065.5% | |
| Diluted EPS [+] | $1.22 | $1.05 | $0.73 | $0.46 | ($1.01) | $1.38 | ($0.86) | $1.38 |
| Growth | 16.2% | 43.8% | 58.5% | -145.6% | -173.2% | -260.5% | -162.3% | |
| |
| Shares outstanding (basic) [+] | 17.2 | 15.9 | 16.8 | 16.9 | 16.8 | 16.3 | 0.0 | 16.8 |
| Growth | 8.0% | -5.4% | -0.6% | 0.7% | 3.0% | 191639.2% | -99.9% | |
| Shares outstanding (diluted) [+] | 17.2 | 15.9 | 16.8 | 17.3 | 16.8 | 16.8 | 15.9 | 17.7 |
| Growth | 8.0% | -5.4% | -2.9% | 3.1% | 0.1% | 5.5% | -9.9% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |